Showing results (11-20 of 222) with videos related to
Sort By:
Pageof 23
Oncoimmunology|November 20, 2012
Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the futureGeorge C PrendergastCancer Cell|October 31, 2003
Signal transduction: putting translation before transcriptionGeorge C PrendergastBreast Disease|February 3, 2005
Farnesyltransferase inhibitors: potential therapeutic for inflammatory breast cancer?George C PrendergastCancer Immunology, Immunotherapy : CII|April 9, 2014
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerGeorge C Prendergast, Courtney Smith, Sunil Thomas, et al.Frontiers in Oncology|September 27, 2018
Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in CancerEric Fox, Thomas Oliver, Melissa Rowe, et al.Cell Cycle (Georgetown, Tex.)|July 6, 2007
Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in fission yeastArivudainambi Ramalingam, George C PrendergastOncotarget|February 4, 2016
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancerJames DuHadaway, George C PrendergastDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Targeting farnesyltransferase: is Ras relevant?George C. Prendergast, Wei DuCancer Biology & Therapy|May 7, 2005
Genetic response to DNA damage: proapoptotic targets of RhoB include modules for p53 response and susceptibility to Alzheimer's diseaseUma Kamasani, George C PrendergastOncoimmunology|November 20, 2012
A perspective on new immune adjuvant principles: Reprogramming inflammatory states to permit clearance of cancer cells and other age-associated cellular pathologiesGeorge C Prendergast, Richard MetzPageof 23